The Business Research Company's Point Of Care Lipid Test Market Report Provides Insights Into Market Evolution And Growth Prospects
LONDON, GREATER LONDON, UNITED KINGDOM, August 24, 2026 /EINPresswire.com/ -- "The point of care lipid test market has experienced significant growth in recent years, driven by advancements in technology and the increasing need for rapid diagnostic solutions. As healthcare systems seek faster and more accessible ways to monitor cardiovascular health, this market is set to expand further. Let’s explore the current market size, growth factors, regional insights, and emerging trends shaping this sector.
Point of Care Lipid Test Market Size and Growth Outlook
The market for point of care lipid tests has shown strong momentum, increasing from $0.74 billion in 2025 to an expected $0.82 billion in 2026, with a compound annual growth rate (CAGR) of 9.7%. This upward trajectory reflects the growing demand for quick and reliable cholesterol and triglyceride testing, fueled by rising cardiovascular disease rates, advancements in biosensor technologies, and greater awareness around cholesterol management. The availability and convenience of point-of-care devices have also played a key role in this expansion.
Download a free sample of the point of care lipid test market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28300&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
Looking ahead, the market is forecasted to continue its upward climb, reaching $1.17 billion by 2030 with a CAGR of 9.4%. Several factors contribute to this anticipated growth, including the integration of point of care lipid tests with mobile applications and cloud-based platforms, wider adoption in home healthcare settings, and increased use in clinics and hospitals. Additionally, innovations such as multi-analyte testing and strategic partnerships between device manufacturers and software developers are expected to drive market development. Key trends during this period include the rise of fingerstick lipid testing, portable analyzers, multi-parameter devices, rapid cardiovascular risk assessments, and home-based monitoring solutions.
Understanding the Point of Care Lipid Test
A point of care lipid test is a rapid diagnostic method that uses a simple fingerstick blood sample to measure cholesterol and triglyceride levels. Unlike traditional testing that requires laboratory analysis, this test provides immediate results to help healthcare professionals assess cardiovascular risk quickly and efficiently. This rapid feedback is essential for ongoing monitoring and timely intervention, especially for patients at risk of heart disease.
View the full point of care lipid test market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-lipid-test-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR
The Impact of Cardiovascular Disease Prevalence on Market Growth
The increasing incidence of cardiovascular diseases (CVDs) is a major driver for the point of care lipid test market. Cardiovascular conditions, which include coronary artery disease, stroke, and hypertension, often stem from atherosclerosis related to abnormal lipid levels. Sedentary lifestyles and reduced physical activity contribute to the rise in obesity and other risk factors, fueling the growth of CVDs worldwide. Point of care lipid testing supports healthcare providers by offering fast, on-site measurements of lipid profiles, enabling early detection and prompt treatment to reduce disease progression.
To illustrate the growing impact of cardiovascular diseases, the American Heart Association reported in January 2024 that deaths in the US due to cardiovascular disease reached 931,578, an increase of 3,000 compared to the previous year’s 928,741 fatalities. This rising trend underscores the urgent need for efficient lipid monitoring tools, reinforcing the expansion potential of the point of care lipid test market.
Regional Dynamics Within the Global Point of Care Lipid Test Market
In 2025, North America held the largest share of the point of care lipid test market, benefiting from advanced healthcare infrastructure and high awareness levels. However, the Asia-Pacific region is poised to experience the fastest growth during the forecast period, driven by increasing healthcare investments, rising cardiovascular disease cases, and expanding access to diagnostic technology. The market report covers various regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive global perspective on market trends and opportunities.
Our 2026 reports feature deeper market intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company"
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

